Form 4 for HQ Horizon Quantum Holdings Ltd.
Accepted 2026-09-15 21:30:10 ET · period of report 2026-06-12 · accession 0001213900-26-100279 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-15 21:30 | 2026-09-12 | HQ | Fitzsimons Joseph Francis | CEO, Dir, 10% | M - OptEx | $0.00 | +14.3K | 14.3K | New | $0 |
| D | 2026-09-15 21:30 | 2026-09-12 | HQ | Fitzsimons Joseph Francis | CEO, Dir, 10% | D - Sale to Iss | $15.22 | -3,438 | 10.9K | -24% | -$52.3K |
| D | 2026-09-15 21:30 | 2026-06-12 | HQ | Fitzsimons Joseph Francis | CEO, Dir, 10% | A - Grant | $0.00 | +229.1K | 229.1K | New | $0 |
| D | 2026-09-15 21:30 | 2026-09-12 | HQ | Fitzsimons Joseph Francis | CEO, Dir, 10% | M - OptEx | $0.00 | +14.3K | 214.8K | +7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Shares | 2026-09-12 | M | A | 14,321 | $0.00 | 14,321 | D | — | — | (F1) On September 12, 2026, 14,321 of Dr. Fitzsimons's RSU's vested. (F1) On September 12, 2026, 14,321 of Dr. Fitzsimons's RSU's vested. (F2) On June 12, 2026 (the "Grant Date"), Dr. Fitzsimons was granted a total of 229,148 unvested restricted stock units ("RSUs"), each representing a contingent right to receive one Class A ordinary share, with no par value ("Class A Ordinary Share"), of Horizon Quantum Holdings Ltd. (the "Company") upon vesting, for no consideration. The RSUs granted to Dr. Fitzsimons vest in sixteen approximately equal installments on successive quarterly anniversaries of the Grant Date and are subject to Dr. Fitzsimons's continued employment with the Company through each applicable vesting date. |
| 2 | Common | Class A Ordinary Shares | 2026-09-12 | D | D | 3,438 | $15.22 | 10,883 | D | — | — | (F1) On September 12, 2026, 14,321 of Dr. Fitzsimons's RSU's vested. (F3) The reported disposition to the Company reflects the settlement in cash of a portion of the RSUs which vested on September 12, 2026, at a price per ordinary share of $15.22, the last reported sales price of the Company's Class A Ordinary Shares on September 11, 2026. (F3) The reported disposition to the Company reflects the settlement in cash of a portion of the RSUs which vested on September 12, 2026, at a price per ordinary share of $15.22, the last reported sales price of the Company's Class A Ordinary Shares on September 11, 2026. |
| 3 | Derivative | Restricted Stock Unit | 2026-06-12 | A | A | 229,148 | $0.00 | 229,148 | D | $0.00 · — to — | 229,148 Class A Ordinary Shares | (F2) On June 12, 2026 (the "Grant Date"), Dr. Fitzsimons was granted a total of 229,148 unvested restricted stock units ("RSUs"), each representing a contingent right to receive one Class A ordinary share, with no par value ("Class A Ordinary Share"), of Horizon Quantum Holdings Ltd. (the "Company") upon vesting, for no consideration. The RSUs granted to Dr. Fitzsimons vest in sixteen approximately equal installments on successive quarterly anniversaries of the Grant Date and are subject to Dr. Fitzsimons's continued employment with the Company through each applicable vesting date. (F2) On June 12, 2026 (the "Grant Date"), Dr. Fitzsimons was granted a total of 229,148 unvested restricted stock units ("RSUs"), each representing a contingent right to receive one Class A ordinary share, with no par value ("Class A Ordinary Share"), of Horizon Quantum Holdings Ltd. (the "Company") upon vesting, for no consideration. The RSUs granted to Dr. Fitzsimons vest in sixteen approximately equal installments on successive quarterly anniversaries of the Grant Date and are subject to Dr. Fitzsimons's continued employment with the Company through each applicable vesting date. (F2) On June 12, 2026 (the "Grant Date"), Dr. Fitzsimons was granted a total of 229,148 unvested restricted stock units ("RSUs"), each representing a contingent right to receive one Class A ordinary share, with no par value ("Class A Ordinary Share"), of Horizon Quantum Holdings Ltd. (the "Company") upon vesting, for no consideration. The RSUs granted to Dr. Fitzsimons vest in sixteen approximately equal installments on successive quarterly anniversaries of the Grant Date and are subject to Dr. Fitzsimons's continued employment with the Company through each applicable vesting date. (F2) On June 12, 2026 (the "Grant Date"), Dr. Fitzsimons was granted a total of 229,148 unvested restricted stock units ("RSUs"), each representing a contingent right to receive one Class A ordinary share, with no par value ("Class A Ordinary Share"), of Horizon Quantum Holdings Ltd. (the "Company") upon vesting, for no consideration. The RSUs granted to Dr. Fitzsimons vest in sixteen approximately equal installments on successive quarterly anniversaries of the Grant Date and are subject to Dr. Fitzsimons's continued employment with the Company through each applicable vesting date. (F2) On June 12, 2026 (the "Grant Date"), Dr. Fitzsimons was granted a total of 229,148 unvested restricted stock units ("RSUs"), each representing a contingent right to receive one Class A ordinary share, with no par value ("Class A Ordinary Share"), of Horizon Quantum Holdings Ltd. (the "Company") upon vesting, for no consideration. The RSUs granted to Dr. Fitzsimons vest in sixteen approximately equal installments on successive quarterly anniversaries of the Grant Date and are subject to Dr. Fitzsimons's continued employment with the Company through each applicable vesting date. |
| 4 | Derivative | Restricted Stock Unit | 2026-09-12 | M | A | 14,321 | $0.00 | 214,827 | D | $0.00 · — to — | 14,321 Class A Ordinary Shares | (F2) On June 12, 2026 (the "Grant Date"), Dr. Fitzsimons was granted a total of 229,148 unvested restricted stock units ("RSUs"), each representing a contingent right to receive one Class A ordinary share, with no par value ("Class A Ordinary Share"), of Horizon Quantum Holdings Ltd. (the "Company") upon vesting, for no consideration. The RSUs granted to Dr. Fitzsimons vest in sixteen approximately equal installments on successive quarterly anniversaries of the Grant Date and are subject to Dr. Fitzsimons's continued employment with the Company through each applicable vesting date. (F1) On September 12, 2026, 14,321 of Dr. Fitzsimons's RSU's vested. (F1) On September 12, 2026, 14,321 of Dr. Fitzsimons's RSU's vested. (F2) On June 12, 2026 (the "Grant Date"), Dr. Fitzsimons was granted a total of 229,148 unvested restricted stock units ("RSUs"), each representing a contingent right to receive one Class A ordinary share, with no par value ("Class A Ordinary Share"), of Horizon Quantum Holdings Ltd. (the "Company") upon vesting, for no consideration. The RSUs granted to Dr. Fitzsimons vest in sixteen approximately equal installments on successive quarterly anniversaries of the Grant Date and are subject to Dr. Fitzsimons's continued employment with the Company through each applicable vesting date. (F2) On June 12, 2026 (the "Grant Date"), Dr. Fitzsimons was granted a total of 229,148 unvested restricted stock units ("RSUs"), each representing a contingent right to receive one Class A ordinary share, with no par value ("Class A Ordinary Share"), of Horizon Quantum Holdings Ltd. (the "Company") upon vesting, for no consideration. The RSUs granted to Dr. Fitzsimons vest in sixteen approximately equal installments on successive quarterly anniversaries of the Grant Date and are subject to Dr. Fitzsimons's continued employment with the Company through each applicable vesting date. |